Associate chief physician
Beijing GoBroad Boren Hospital
China / Beijing
Highlights
Expertise Specializes in the treatment of refractory and relapsed acute lymphoblastic leukemia/myeloid leukemia, mixed lineage leukemia, lymphoma, and other malignant hematologic lymphoid system tumors using CAR-T, antibodies, targeted drugs, chemotherapy, as well as the diagnosis and treatment of common diseases such as chronic granulocytic leukemia, immune thrombocytopenic purpura, aplastic anemia, and myelodysplastic syndromes.
Chief physician
Beijing GoBroad Boren Hospital
China / Beijing
Highlights
He specializes in diagnosing and treating various types of anemia, acute and chronic leukemia, lymphoma, multiple myeloma, and other hematological diseases. He has rich experience in diagnosing and treating refractory and relapsed leukemia and lymphoma.
Chief physician
Beijing GoBroad Boren Hospital
China / Beijing
Highlights
She has primarily been engaged in the diagnosis and treatment of various refractory/recurrent hematologic malignancies, especially in CAR-T cell immunotherapy and related clinical research.
Dean of Research
Beijing GoBroad Boren Hospital
China / Beijing
Highlights
She specializes in the integrated diagnosis (combining clinical history with various laboratory diagnostic techniques) and comprehensive treatment (chemotherapy, immunotherapy, targeted therapy, traditional Chinese medicine, etc.) of all types of malignant hematological tumors, with a focus on personalized and precise treatment, especially proficient in the immunotherapy of hematologic tumors.
Chief physician
Hematology Hospital, Chinese Academy of Medical Sciences
China / Tian Jin
Highlights
He has been engaged in clinical and basic research on hematological diseases for more than 30 years and is one of the leading subjects in the field of lymphoma in China.Main research directions: molecular pathogenesis and effective treatment strategies of lymphatic system tumors, clinical and relevant basis of hematopoietic stem cell transplantation.
Chief physician
The First Affiliated Hospital of Zhengzhou University
China / Zheng Zhou
Highlights
Diagnosis and treatment of various types of acute leukemia, chronic leukemia, multiple myeloma, malignant lymphoma, aplastic anemia, myelodysplastic syndrome and other diseases, and in-depth research on various plasma cell diseases, multiple myeloma and amyloidosis, Especially good at hematopoietic stem cell transplantation/bone marrow transplantation/umbilical cord blood transplantation in the treatment of malignant hematological diseases (acute leukemia/chronic leukemia/malignant lymphoma/multiple myeloma/myelodysplastic syndrome, etc.).
Chief physician
The First Affiliated Hospital of Zhejiang University School of Medicine
China / Hang Zhou
Highlights
Diagnosis and treatment of multiple myeloma, lymphoma, leukemia, MDS and other blood system diseases, allogeneic hematopoietic stem cell transplantation treatment of malignant blood diseases
Chief physician
Henan Cancer Hospital
China / Zheng zhou
Highlights
Diagnosis and treatment of acute and chronic leukemia, lymphoma, myeloma and other blood diseases, including chronic myelogenous leukemia, acute myeloid leukemia, acute lymphoblastic leukemia, etc.
Chief physician
Xiangya Third Hospital, Central South University
China / Hu Nan
Highlights
Basic research on multiple myeloma, clinical research on hematological diseases associated infections, hematopoietic stem cell transplantation, cellular immunotherapy.
Chief physician
Nanjing Gulou Hospital
China / Nan Jing
Highlights
He is good at the diagnosis and differential diagnosis of various hemocytopenia, diagnosis and treatment of multiple myeloma, acute and chronic leukemia, myelodysplastic syndrome, and cell therapy technology such as hematopoietic stem cell transplantation.
Chief physician
Peking University People's Hospital
China / Beijing
Highlights
Diagnosis and treatment of hematologic malignancies such as multiple myeloma and cell immunotherapy.
Chief physician
Lu-Daopei Hospital
China / Beijing
Highlights
Leukaemia, multiple myeloma, lymphoma, aplastic anaemia, acute and chronic myeloproliferative disorders.CAR T cell immunotherapy.